Eduardo Silva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Eduardo Silva has a total of 34 co-authors. Here are the top co-authors by number of shared publications:
Celso Nunes
Department of Angiology and Vascular Surgery, Coimbra Hospital and University Centre, Coimbra, Portugal
4 shared publications- Joana Cruz Silva
Angiology and Vascular Surgery Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
2 shared publications Leonor Baldaia
Department of Angiology and Vascular Surgery, Coimbra Hospital and University Centre, Coimbra, Portugal
2 shared publications- Leonor Baldaia
Department of Angiology and Vascular Surgery, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
2 shared publications - Luís F. Antunes
Department of Angiology and Vascular Surgery, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal
2 shared publications Miguel Castro
Department of Angiology and Vascular Surgery, Coimbra Hospital and University Centre, Coimbra, Portugal
2 shared publications
Latest Publications
- Open Access
- 9 July 2026
- Published by Springer Nature in BMC Medical Imaging
- Vol. 26 (1)
Pedal acceleration time as a diagnostic and prognostic tool in peripheral artery disease: systematic review and meta-analysis
Background: Wound healing in chronic limb-threatening ischaemia in peripheral artery disease (PAD) remains clinically challenging. Accurate perfusion assessment may predict limb outcomes. Standard measures ankle-brachial index (ABI) and transcutaneous oxygen pressure have limitations. The ABI, the guideline-recommended first-line diagnostic tool, has well-recognised limitations in patients. Pedal acceleration time (PAT), measured by duplex ultrasound from onset to peak arterial systole in the pedal arteries, shows promise as a prognostic marker, though its diagnostic and prognostic performance has not been fully validated. This study aimed to perform a systematic review and meta-analysis evaluating PAT’s diagnostic accuracy compared with ABI in detecting lower-limb ischaemia. Secondary objectives included assessing PAT’s prognostic value for wound healing and amputation risk. Methods: Three electronic databases MEDLINE, Scopus, and Web of Science, were systematically searched for studies evaluating PAT values and wound healing in PAD patients. Wound healing incidence and PAT-ABI correlations were pooled according to Preferred Reporting Items for Systematic reviews and Meta-Analyses of Diagnostic Test Accuracy studies (PRISMA-DTA) guidelines. Pooled diagnostic indices, including sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio with 95% confidence intervals were calculated. Study quality was assessed using the National Heart, Lung, and Blood Institute (NHLBI) Study Quality Assessment Tool for observational cohort and cross-sectional designs. Results: Seventeen studies (1749 patients) were included as following: 8 cross-sectional, 1 observational prospective, 3 observational retrospective, 4 cohort (3 retrospective, 1 prospective), and 1 case-control study. PAT demonstrated good diagnostic accuracy with pooled 0.72 (95% CI 0.68–0.76) sensitivity, 0.84 (95% CI 0.79–0.88) specificity, 4.38 (95% CI 3.35–5.73) positive likelihood ratio, 0.25 (95% CI 0.19–0.33) negative likelihood ratio, and 14.85 (95% CI 10.02–22.01) diagnostic odds ratio, indicating robust discrimination compared to ABI. The selected studies, referring to the period 2019–2025, reported an association between higher PAT values and worse wound healing outcomes and increased amputation risk. Due to insufficient and non-standardised data, PAT’s prognostic pooled analysis for wound healing was not feasible. Conclusion: PAT accurately detected clinically significant lower-limb ischaemia compared to ABI. Faster PAT values correlated to higher ABI and favorable wound healing outcomes, whereas prolonged PAT indicated higher risk of non-healing wounds and major amputation. These results support PAT as a useful duplex-based complement to existing perfusion tests.
- 9 July 2026
- Published by Springer Nature in BMC Medical Imaging
- Vol. 26 (1)
Open AccessPedal acceleration time as a diagnostic and prognostic tool in peripheral artery disease: systematic review and meta-analysis
Background: Wound healing in chronic limb-threatening ischaemia in peripheral artery disease (PAD) remains clinically challenging. Accurate perfusion assessment may predict limb outcomes. Standard measures ankle-brachial index (ABI) and transcutaneous oxygen pressure have limitations. The ABI, the guideline-recommended first-line diagnostic tool, has well-recognised limitations in patients. Pedal acceleration time (PAT), measured by duplex ultrasound from onset to peak arterial systole in the pedal arteries, shows promise as a prognostic marker, though its diagnostic and prognostic performance has not been fully validated. This study aimed to perform a systematic review and meta-analysis evaluating PAT’s diagnostic accuracy compared with ABI in detecting lower-limb ischaemia. Secondary objectives included assessing PAT’s prognostic value for wound healing and amputation risk. Methods: Three electronic databases MEDLINE, Scopus, and Web of Science, were systematically searched for studies evaluating PAT values and wound healing in PAD patients. Wound healing incidence and PAT-ABI correlations were pooled according to Preferred Reporting Items for Systematic reviews and Meta-Analyses of Diagnostic Test Accuracy studies (PRISMA-DTA) guidelines. Pooled diagnostic indices, including sensitivity, specificity, positive and negative likelihood ratios, and diagnostic odds ratio with 95% confidence intervals were calculated. Study quality was assessed using the National Heart, Lung, and Blood Institute (NHLBI) Study Quality Assessment Tool for observational cohort and cross-sectional designs. Results: Seventeen studies (1749 patients) were included as following: 8 cross-sectional, 1 observational prospective, 3 observational retrospective, 4 cohort (3 retrospective, 1 prospective), and 1 case-control study. PAT demonstrated good diagnostic accuracy with pooled 0.72 (95% CI 0.68–0.76) sensitivity, 0.84 (95% CI 0.79–0.88) specificity, 4.38 (95% CI 3.35–5.73) positive likelihood ratio, 0.25 (95% CI 0.19–0.33) negative likelihood ratio, and 14.85 (95% CI 10.02–22.01) diagnostic odds ratio, indicating robust discrimination compared to ABI. The selected studies, referring to the period 2019–2025, reported an association between higher PAT values and worse wound healing outcomes and increased amputation risk. Due to insufficient and non-standardised data, PAT’s prognostic pooled analysis for wound healing was not feasible. Conclusion: PAT accurately detected clinically significant lower-limb ischaemia compared to ABI. Faster PAT values correlated to higher ABI and favorable wound healing outcomes, whereas prolonged PAT indicated higher risk of non-healing wounds and major amputation. These results support PAT as a useful duplex-based complement to existing perfusion tests.
- Open Access
- 2 February 2024
- Published by Elsevier in EJVES Vascular Forum
- Vol. 61, 77-80
Infected Thrombosed Popliteal Artery Aneurysm With Cutaneous Fistula
- 2 February 2024
- Published by Elsevier in EJVES Vascular Forum
- Vol. 61, 77-80
Open AccessInfected Thrombosed Popliteal Artery Aneurysm With Cutaneous Fistula
- Open Access
- 11 November 2023
- Published by Elsevier in EJVES Vascular Forum
- Vol. 61, 8-11
Aneurysmal Degeneration of the Brachial Artery Following Chronic Arteriovenous Fistula Ligation
- 11 November 2023
- Published by Elsevier in EJVES Vascular Forum
- Vol. 61, 8-11
Open AccessAneurysmal Degeneration of the Brachial Artery Following Chronic Arteriovenous Fistula Ligation
- Open Access
- 22 June 2023
- Published by Elsevier in Annals of Vascular Surgery - Brief Reports and Innovations
- Vol. 3 (3) , 100210
Treatment of coral reef aorta with descending thoracic aorta bypass: A case report and literature review
- 22 June 2023
- Published by Elsevier in Annals of Vascular Surgery - Brief Reports and Innovations
- Vol. 3 (3) , 100210
Open AccessTreatment of coral reef aorta with descending thoracic aorta bypass: A case report and literature review
- Open Access
- 27 February 2023
- Published by Elsevier in EJVES Vascular Forum
- Vol. 58, 15-18
Giant Sac Growth: A Hybrid Approach to Treat a Misdiagnosed Late Type IIIb Endoleak
- 27 February 2023
- Published by Elsevier in EJVES Vascular Forum
- Vol. 58, 15-18
Open AccessGiant Sac Growth: A Hybrid Approach to Treat a Misdiagnosed Late Type IIIb Endoleak
- Open Access
- 22 March 2022
- Published by Elsevier in EJVES Vascular Forum
- Vol. 54, e17
Acute Limb Ischaemia: Charlson Comorbidity Index Adjusted to Age, Biomarkers, and Prognosis
- 22 March 2022
- Published by Elsevier in EJVES Vascular Forum
- Vol. 54, e17
Open AccessAcute Limb Ischaemia: Charlson Comorbidity Index Adjusted to Age, Biomarkers, and Prognosis
- Open Access
- 26 October 2006
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 6 (1) , 6
A multinodular goiter as the initial presentation of a renal cell carcinoma harbouring a novel VHL mutation
Secondary involvement of the thyroid gland is rare. Often the origin of the tumor is difficult to identify from the material obtained by fine-needle aspiration cytology. Renal cell carcinoma of the clear-cell type is one of the more common carcinomas to metastasize to the thyroid gland. Somatic mutations of the von Hippel-Lindau tumor suppressor gene are associated with the sporadic form of this tumor. We aimed to illustrate the potential utility of DNA based technologies to search for specific molecular markers in order to establish the anatomic site of origin. A 54-yr-old Caucasian male complaining of a rapidly increasing neck tumor was diagnosed as having a clear-cell tumor by fine-needle aspiration cytology. A positive staining for cytokeratin as well as for vimentin and CD10 in the absence of staining for thyroglobulin, calcitonin and TTF1 suggested a renal origin confirmed by computed tomography. Using frozen RNA, obtained from cells left inside the needle used for fine needle aspiration cytology, it was possible to identify a somatic mutation (680 delA) in the VHL gene. In the presence of a clear-cell tumor of the thyroid gland, screening for somatic mutations in the VHL gene in material derived from thyroid aspirates might provide additional information to immunocytochemical studies and therefore plays a contributory role to establish the final diagnosis. Moreover, in a near future, this piece of information might be useful to define a targeted therapy.
- 26 October 2006
- Published by Springer Nature in BMC Endocrine Disorders
- Vol. 6 (1) , 6
Open AccessA multinodular goiter as the initial presentation of a renal cell carcinoma harbouring a novel VHL mutation
Secondary involvement of the thyroid gland is rare. Often the origin of the tumor is difficult to identify from the material obtained by fine-needle aspiration cytology. Renal cell carcinoma of the clear-cell type is one of the more common carcinomas to metastasize to the thyroid gland. Somatic mutations of the von Hippel-Lindau tumor suppressor gene are associated with the sporadic form of this tumor. We aimed to illustrate the potential utility of DNA based technologies to search for specific molecular markers in order to establish the anatomic site of origin. A 54-yr-old Caucasian male complaining of a rapidly increasing neck tumor was diagnosed as having a clear-cell tumor by fine-needle aspiration cytology. A positive staining for cytokeratin as well as for vimentin and CD10 in the absence of staining for thyroglobulin, calcitonin and TTF1 suggested a renal origin confirmed by computed tomography. Using frozen RNA, obtained from cells left inside the needle used for fine needle aspiration cytology, it was possible to identify a somatic mutation (680 delA) in the VHL gene. In the presence of a clear-cell tumor of the thyroid gland, screening for somatic mutations in the VHL gene in material derived from thyroid aspirates might provide additional information to immunocytochemical studies and therefore plays a contributory role to establish the final diagnosis. Moreover, in a near future, this piece of information might be useful to define a targeted therapy.